Brentuximab Vedotin

Red

Brand Name(s):Adcetris

Indication:Lymphoma (Hodgkin relapsed or refractory CD30+ and systemic anaplastic large cell lymphoma (sALCL) untreated, relapsed or refractory

Rationale:1,2

Considered:Sep-12

Review Date:Oct-25

Comments:
NICE TA641 _____________Brentuximab vedotin with cyclophosphamide, doxorubicin and prednisone (CHP) is recommended as an option for untreated systemic anaplastic large cell lymphoma in adults.